Researchers compared the 3 diagnostic criteria and assessed the performance of an additional set of criteria in the diagnosis of fibromyalgia.
The FDA has expanded the approval of Cymbalta to include treatment of fibromyalgia in pediatric patients 13 to 17 years of age.
Researchers investigated the association of fibromyalgia and widespread pain with mortality.
According to the investigators, when managing patients with inflammatory rheumatic conditions in daily clinical practice, clinicians must assess signs and symptoms of fibromyalgia.
Four weeks of active transcutaneous electrical nerve stimulation (TENS) results in significant improvement in movement-evoked pain and other clinical outcomes compared with placebo-TENS or no TENS.
Researchers compared the effects of repetitive transcranial magnetic stimulation (rTMS) with a combination of multicomponent therapy and rTMS on pain in patients with fibromyalgia.
There is an association between a history of intimate partner violence (IPV) and the development of functional syndromes, including fibromyalgia and chronic fatigue syndrome, in women.
Researchers evaluated the effect of fibromyalgia on the clinical outcomes of biologics in patients with psoriatic arthritis.
Researchers assessed the sensitivity of Bath Ankylosing Spondylitis Disease
Activity Index, Ankylosing Spondylitis Disease Activity Score and C-reactive protein against response to biologics in axial spondyloarthritis with coexistent fibromyalgia.
Researchers evaluated the safety and efficacy of a sublingual formulation of cyclobenzaprine in fibromyalgia.
